Emily Howe
Columbia University(US)
Publications by Year
Research Areas
Lung Cancer Treatments and Mutations, HER2/EGFR in Cancer Research, Chronic Lymphocytic Leukemia Research, Clostridium difficile and Clostridium perfringens research, Lung Cancer Research Studies
Most-Cited Works
- → EGFR Mutations and ALK Rearrangements Are Associated with Low Response Rates to PD-1 Pathway Blockade in Non–Small Cell Lung Cancer: A Retrospective Analysis(2016)1,214 cited
- → Patient-derived models of acquired resistance can identify effective drug combinations for cancer(2014)731 cited
- → RB loss in resistant EGFR mutant lung adenocarcinomas that transform to small-cell lung cancer(2015)626 cited
- → Variation in Mechanisms of Acquired Resistance Among EGFR-Mutant NSCLC Patients With More Than 1 Postresistant Biopsy(2014)17 cited
- → Predictors of atrial fibrillation on implantable cardiac monitoring for cryptogenic stroke(2021)12 cited
- → Medication Exposure and Risk of Recurrent Clostridium difficile Infection in Community‐Dwelling Older People and Nursing Home Residents(2017)9 cited
- → Variation in mechanisms of acquired resistance (AR) among EGFR-mutant NSCLC patients with more than one post-resistant biopsy.(2014)8 cited
- → Proton pump inhibitors and 180-day mortality in the elderly after Clostridium difficile treatment(2019)6 cited
- Abstract 15985: Real-World Use of Implantable Loop Recorder Following Cryptogenic Stroke: Who Actually Benefits From Long Term Monitoring and How Long Should They Remain Implanted?(2019)